News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Application of Antibody-Based Glycan Detection

Nov 27th 2024
Introduction for simple, highly sensitive analytical protocols using antibodies. Antibody reagents suitable for various detection methods
Read More

An update on the patentability of antibodies at the European Patent Office

Mar 16th 2024
The EPO has recently issued updated Guidelines for Examination, which entered into force on 1 March 2024. Some of the most significant modifications have been made to the guidance surroundin...
Read More

From Discovery to Clinical Testing: HistologiX and Antibody Analytics Forge Grou...

Sep 12th 2023
HistologiX has recently announced that they have entered a strategic partnership with Antibody Analytics, a leading provider of immunology research services and characterisation of antibody-...
Read More

Antibodies at the EPO

Mar 24th 2021
Gareth Williams, Partner at Marks & Clerk, discusses what changed for antibodies on 1st March.
Read More

Innovative synthetic antibody (Aptamer) test for SARS Cov-2 in development at Ap...

Mar 30th 2020
This test will omit the need for lab-based PCR testing for the virus antigen, massively scaling up the number of SARS Cov-2 virus tests that can be conducted in a community setting, partner...
Read More

Bio-Rad Introduces Anti-Vedolizumab Antibodies

May 15th 2018
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release of a range of anti-vedolizumab antibod...
Read More

Glythera appoints Professor Kerry Chester to SAB

Apr 30th 2018
Glythera Limited (Glythera), the next-generation antibody drug conjugate (ADC) development company, today announces that it has appointed Professor Kerry Chester to its Scientific Advisory B...
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners